Akebia Therapeutics(AKBA)
搜索文档
Akebia Therapeutics(AKBA) - 2019 Q1 - Quarterly Report
2019-05-10 04:07
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-36352 | --- | --- | |--------------------------------------------------------------------------------------|------------------------------------------------------ ...
Akebia Therapeutics(AKBA) - 2019 Q1 - Earnings Call Transcript
2019-05-10 03:23
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q1 2019 Results Conference Call May 9, 2019 9:00 AM ET Company Participants Kristen Sheppard - Vice President of Investor Relations John Butler - Chief Executive Officer Jason Amello - Chief Financial Officer Conference Call Participants Chris Raymond - Piper Jaffray Alex Bouilloux - Mizuho Securities Eric Joseph - JP Morgan Chad Messer - Needham & Company Ed Arce - H.C. Wainwright Robert Hazlett - BTIG Ishmael Asante - Morgan Stanley Kennen MacKay - RBC Capital Marke ...
Akebia Therapeutics(AKBA) - 2018 Q4 - Annual Report
2019-03-27 04:07
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-36352 AKEBIA THERAPEUTICS, INC. (Exact name of registrant as specified in its charter) Delaware 20-8756903 (State or other jurisdiction of incorporation or organizatio ...
Akebia Therapeutics(AKBA) - 2018 Q4 - Earnings Call Transcript
2019-03-19 11:17
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q4 2018 Earnings Conference Call March 18, 2019 4:30 PM ET Company Participants John Butler - CEO, President & Director Jason Amello - SVP, CFO & Treasurer Michel Dahan - SVP & Chief Business Officer Douglas Jermasek - VP, Marketing & Strategy Rita Jain - SVP & Chief Medical Officer Conference Call Participants Christopher Raymond - Piper Jaffray Companies Kennen MacKay - RBC Capital Markets Difei Yang - Mizuho Securities Reni Benjamin - Raymond James & Associates Rob ...